BTA-9881

• Description:

  BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  390.82

• Molecular Formula:

  C21H15ClN4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  RSV

• CAS Number:

  1646857-24-0